THBS1 expression correlates with CRC mesenchymal phenotype, immunosuppression, and poor prognosis, promoting metastasis by exhausting cytotoxic T cells and impairing angiogenesis, especially at metastatic sites (48). This evidence concerns the gene THBS1 and colorectal carcinoma.